GLOBE model finalised, with narrowed scope and fewer savings
CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.
Newsletters and Deep Dive digital magazine
CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.
Two Indian nationals are facing charges relating to the sale of counterfeit versions of Novo's diabetes treatment Ozempic to distributors in the US.
Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
Sweden's Egetis has won approval in the US for the first-ever treatment for people living with the ultra-rare genetic disease MCT8 deficiency.
Agentic Call Reports help turn field observations into scalable, actionable insights generating Commercial Evidence.
Editor's Picks
Newsletters and Deep Dive
digital magazine